{{Rsnum
|rsid=80356668
|Chromosome=11
|Orientation=minus
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene=INS
|position=2160829
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=INS,INS-IGF2
}}{{omim
|id=176730
|rsnum=80356668
|variant=0002
}}
{{omim
|id=176730
|rsnum=80356668
|variant=0013
}}{{ClinVar
|rsid=80356668
|Reversed=1
|FwdREF=T
|FwdALT=C,G
|REF=A
|ALT=C,G
|RSPOS=2182059
|CHROM=11
|dbSNPBuildID=132
|SSR=0
|SAO=1
|VP=0x050368000000000002110100
|GENEINFO=INS:3630; INS-IGF2:723961
|GENE_NAME=INS; INS-IGF2
|GENE_ID=3630; 723961
|WGT=0
|VC=SNV
|CLNALLE=1; 2
|CLNHGVS=NC_000011.9:g.2182059A>C; NC_000011.9:g.2182059A>G
|CLNSRC=GeneReviews; OMIM Allelic Variant; UniProtKB (variants)
|CLNORIGIN=0; 1
|CLNSRCID=NBK1447; 176730.0013; VAR_063731; 176730.0002
|CLNSIG=5
|CLNCUI=C1833104
|CLNDBN=Permanent neonatal diabetes mellitus; Insulin los angeles
|Disease=Permanent neonatal diabetes mellitus; Insulin los angeles
|CLNACC=RCV000014321.24; RCV000014307.17
|Tags=RV;PM;PMC;S3D;SLO;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen:OMIM:Orphanet:Orphanet
|CLNDSDBID=NBK1447:C1833104:606176:79134:99885
}}{{PMID Auto
|PMID=17855560
|Title=Insulin gene mutations as a cause of permanent neonatal diabetes.
|OA=1
}}{{PMID Auto
|PMID=17047922
|Title=Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene.
}}

{{PMID Auto
|PMID=18171712
|Title=Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group.
}}